Objective: To review the evidence concerning treatment-related gynecomastia in patients
taking spironolactone, antiandrogens, 5 alpha-reductase inhibitors, lipid-lowering and …

Introduction: Drugs are estimated to cause about 10–25% of all cases of gynecomastia. Over
the course of several decades, multiple medications have been implicated in the …

Gynaecomastia has been associated with a large variety of drugs in the literature. However,
a causal relation of the incidence of gynaecomastia to a certain drug should be considered …

Gynecomastia is caused by drugs in 10–25% of all cases. The pathophysiologic mechanism
for some drugs includes exogenous estrogens exposure, medications that cause …

The patient had attempted suicide by consuming methanol. On admission, his methanol
level was 46 (normal< 2) mmol/L. He was unconscious, with generalized rigidity …

Aims Drug-induced gynecomastia accounts for up to 25% of cases of gynecomastia. The
objective of the present study was to provide a comprehensive overview of drug-induced …

Purpose A large number of medications have been implicated in the genesis of
gynecomastia. However, gynecomastia is common in men, asymptomatic, increases with …

OBJECTIVE To describe what we believe is the first reported case of synergistic
gynecomastia during treatment of depressive and anxiety disorders when sertraline was …

Objective Case reports have suggested an increased risk of gynecomastia with HMG‐CoA
reductase inhibitors (ie, statins). A recent meta‐analysis also found that statins decrease …

Drugs account for about 20% of gynecomastia cases in men. As a number of factors can
alter the estrogen: androgen ratio, several pathophysiologic mechanisms are associated …